IgA-nefropátia: vizsgálatok itt: Kína
53 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePhase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
- Where
- Beijing, Changchun, Changsha, Huangshan City, Linyi, Shanghai, Wuhu, Xi'an, Zhanjiang
- Életkor
- 18 év and over
- People
- 370
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07390123 - No phaseTaking peopleEarly Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07585981 - Korai 1. fázisTaking peopleCD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
- Where
- Hangzhou
- Életkor
- 3 év and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07586267 - 2. fázisTaking peopleA Study of SHR-2173 in Participants With Primary IgA Nephropathy
- Where
- Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 84
- Run by
- Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07354932 - Korai 1. fázisTaking peopleA Study of YKST02 in Participants With Primary IgA Nephropathy
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07498673 - 2/3. fázisCsak meghívásosTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Jinan, Nanchang, Wuxi, Yibin
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659 - 2. fázisNot yet taking people in KínaSLN12140 in Adult Participants With IgA Nephropathy in China
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 48
- Run by
- Linno Pharmaceuticals, Inc.
See details and how to joinNCT07553494 - Korai 1. fázisNot yet taking people in KínaEfficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
- Where
- Xi'an
- Életkor
- 18 év to 65 év
- People
- 15
- Run by
- Air Force Military Medical University, China
See details and how to joinNCT07535138 - No phaseTaking peopleIgA Nephropathy Biomarkers Evaluation Study (INTEREST)
- Where
- Guangzhou
- Életkor
- 14 év and over
- People
- 2000
- Run by
- Sun Yat-sen University
See details and how to joinNCT02954419 - 1/2. fázisTaking peopleA Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 130
- Run by
- Beijing Mabworks Biotech Co., Ltd.
See details and how to joinNCT07375758 - Korai 1. fázisTaking peopleAllogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
- Where
- Hangzhou
- Életkor
- 3 év and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07507201 - 2. fázisNot yet taking people in KínaEfficacy and Safety Study of HS-10542 for IgA Nephropathy
- Where
- Beijing
- Életkor
- 18 év to 74 év
- People
- 90
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07474636 - 1. fázisTaking peopleCAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
- Where
- Hangzhou
- Életkor
- 3 év and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07305116 - No phaseTaking peopleA Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Sichuan Provincial People's Hospital
See details and how to joinNCT06676007 - Korai 1. fázisTaking peopleAnti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
- Where
- Hangzhou
- Életkor
- 3 év and over
- People
- 36
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06792799 - 2. fázisNot yet taking people in KínaStudy of CM313 in Subject With IgA Nephropathy
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 106
- Run by
- Keymed Biosciences Co.Ltd
See details and how to joinNCT06830395 - 4. fázisTaking peopleNefecon and Ambrisentan in IgA Nephropathy
- Where
- Changchun
- Életkor
- 18 év to 70 év
- People
- 129
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07030894 - Korai 1. fázisCsak meghívásosA Study of Cizutamig in Patients With Immunoglobulin A Nephropathy
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 15
- Run by
- Peking University First Hospital
See details and how to joinNCT07135219 - 3. fázisTaking peopleA Trial of HRS-5965 Capsule in Primary IgA Nephropathy
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 378
- Run by
- Chengdu Suncadia Medicine Co., Ltd.
See details and how to joinNCT07014826 - 3. fázisTaking peopleA Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 360
- Run by
- Biocity Biopharmaceutics Co., Ltd.
See details and how to joinNCT06819826 - 1/2. fázisNot yet taking people in KínaA Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
- Where
- Baotou, Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning, Ningbo, Shanghai, Wuxi, Xiamen, Xi’an, Xingtai, Yantai, Yinchuan
- Életkor
- 18 év and over
- People
- 99
- Run by
- Sinocelltech Ltd.
See details and how to joinNCT06774664 - No phaseTaking peopleRaman Spectroscopy Diagnosis of Kidney Diseases
- Where
- Jinan
- People
- 200
- Run by
- Zunsong Wang
See details and how to joinNCT06760845 - No phaseTaking peopleEfficacy and Safety of Telitacicept in IgAN
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 118
- Run by
- Ruijin Hospital
See details and how to joinNCT06654596 - 2. fázisNot yet taking people in KínaStudy to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 72
- Run by
- Wuhan Createrna Science and Technology Co., Ltd
See details and how to joinNCT06687174 - 2. fázisTaking peopleClinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 70
- Run by
- Keymed Biosciences Co.Ltd
See details and how to joinNCT05775042